INTRODUCTION: In an effort to administer life-saving transfusions quickly, some trauma centers maintain thawed plasma (TP). According to AABB, TP is approved for transfusion for up to five days when stored at 1-6° C. However, the alterations in microparticles (MP) contained in the plasma, which are an integral component of plasma's hemostatic capacity, are not well characterized. We report on MP changes in TP between its initial thaw (FFP-0) and five days (FFP-5) of storage. MATERIALS AND METHODS: FFP units (n=30) were thawed at 37° C and kept refrigerated for five days. Phenotypes of residual cells, which include platelets, erythrocytes, leukocytes, monocytes, endothelial cells, and MP counterparts of each cell type, were analyzed by flow cytometry. Functional assays were used for MP procoagulant activity, plasma thrombin generation, and clotting properties (thromboelastography). RESULTS: In FFP-0 the majority (94%) of residual cells were platelets, along with significant levels of platelet MPs (4408 × 10(3)/L). FFP-5 showed a decline in MP count by 50% (p<0.0001), and procoagulant activity by 29% (p<0.0001). FFP-5 exhibited only 54% (p<0.0001) of the potential for thrombin generation as FFP-0, while thromboelastography indicated a slower clotting response (p<0.0001) and a longer delay in reaching maximum clot (p<0.01). Removal of MP by filtration resulted in reduced thrombin generation, while the MP replacement restored it. CONCLUSIONS: Decline in MP with storage contributes to FFP-5's reduced ability to provide the hemostatic potential exhibited by FFP-0, suggesting the presence of platelet MPs in freshly TP may be beneficial and protective in the initial treatment of hemorrhage.
INTRODUCTION: In an effort to administer life-saving transfusions quickly, some trauma centers maintain thawed plasma (TP). According to AABB, TP is approved for transfusion for up to five days when stored at 1-6° C. However, the alterations in microparticles (MP) contained in the plasma, which are an integral component of plasma's hemostatic capacity, are not well characterized. We report on MP changes in TP between its initial thaw (FFP-0) and five days (FFP-5) of storage. MATERIALS AND METHODS: FFP units (n=30) were thawed at 37° C and kept refrigerated for five days. Phenotypes of residual cells, which include platelets, erythrocytes, leukocytes, monocytes, endothelial cells, and MP counterparts of each cell type, were analyzed by flow cytometry. Functional assays were used for MP procoagulant activity, plasma thrombin generation, and clotting properties (thromboelastography). RESULTS: In FFP-0 the majority (94%) of residual cells were platelets, along with significant levels of platelet MPs (4408 × 10(3)/L). FFP-5 showed a decline in MP count by 50% (p<0.0001), and procoagulant activity by 29% (p<0.0001). FFP-5 exhibited only 54% (p<0.0001) of the potential for thrombin generation as FFP-0, while thromboelastography indicated a slower clotting response (p<0.0001) and a longer delay in reaching maximum clot (p<0.01). Removal of MP by filtration resulted in reduced thrombin generation, while the MP replacement restored it. CONCLUSIONS: Decline in MP with storage contributes to FFP-5's reduced ability to provide the hemostatic potential exhibited by FFP-0, suggesting the presence of platelet MPs in freshly TP may be beneficial and protective in the initial treatment of hemorrhage.
Authors: Kenji Inaba; Bernardino C Branco; Peter Rhee; John B Holcomb; Lorne H Blackbourne; Ira Shulman; Janice Nelson; Demetrios Demetriades Journal: Arch Surg Date: 2010-09
Authors: Jeffrey L Johnson; Ernest E Moore; Jeffry L Kashuk; Anirban Banerjee; C Clay Cothren; Walter L Biffl; Angela Sauaia Journal: Arch Surg Date: 2010-10
Authors: S Robert; P Poncelet; R Lacroix; L Arnaud; L Giraudo; A Hauchard; J Sampol; F Dignat-George Journal: J Thromb Haemost Date: 2008-10-18 Impact factor: 5.824
Authors: John R Hess; Karim Brohi; Richard P Dutton; Carl J Hauser; John B Holcomb; Yoram Kluger; Kevin Mackway-Jones; Michael J Parr; Sandro B Rizoli; Tetsuo Yukioka; David B Hoyt; Bertil Bouillon Journal: J Trauma Date: 2008-10
Authors: Joost J van Veen; Alex Gatt; Annette E Bowyer; Peter C Cooper; Steve Kitchen; Mike Makris Journal: Thromb Res Date: 2008-11-13 Impact factor: 3.944
Authors: Philip C Spinella; Christopher L Carroll; Ilene Staff; Ronald Gross; Jacqueline Mc Quay; Lauren Keibel; Charles E Wade; John B Holcomb Journal: Crit Care Date: 2009-09-22 Impact factor: 9.097
Authors: Anastasios G Kriebardis; Marianna H Antonelou; Hara T Georgatzakou; Vassilis L Tzounakas; Konstantinos E Stamoulis; Issidora S Papassideri Journal: Blood Transfus Date: 2016-02-22 Impact factor: 3.443
Authors: Chaojun Duan; Yanna Cao; Xiyun Deng; Weiwei Wang; Wenli Yang; Xianghua Liu; Zhuchu Chen; Shibani Pati; Rosemary A Kozar; Ernest A Gonzalez; Charles E Wade; John B Holcomb; Tien C Ko Journal: Shock Date: 2011-07 Impact factor: 3.454
Authors: Thomas Thiele; Gregor Hron; Sarah Kellner; Christina Wasner; Antje Westphal; Theodore E Warkentin; Andreas Greinacher; Kathleen Selleng Journal: Blood Transfus Date: 2015-07-09 Impact factor: 3.443
Authors: Nena Matijevic; Yao-Wei W Wang; Charles E Wade; John B Holcomb; Bryan A Cotton; Martin A Schreiber; Peter Muskat; Erin E Fox; Deborah J Del Junco; Jessica C Cardenas; Mohammad H Rahbar; Mitchell Jay Cohen Journal: Thromb Res Date: 2014-07-22 Impact factor: 3.944
Authors: Emily F Midura; Joshua W Kuethe; Teresa C Rice; Rosalie Veile; Lisa G England; Lou Ann Friend; Charles C Caldwell; Michael D Goodman Journal: Shock Date: 2016-01 Impact factor: 3.454
Authors: Nena Matijevic; Yao-Wei W Wang; John B Holcomb; Rosemary Kozar; Jessica C Cardenas; Charles E Wade Journal: J Extracell Vesicles Date: 2015-12-17
Authors: Sahithi J Kuravi; Clara M Yates; Mark Foster; Paul Harrison; Jon Hazeldine; Peter Hampson; Chris Watson; Antonio Belli; Mark Midwinter; Gerard B Nash Journal: PLoS One Date: 2017-08-24 Impact factor: 3.240
Authors: Mathijs R Wirtz; Jordy Jurgens; Coert J Zuurbier; Joris J T H Roelofs; Philip C Spinella; Jennifer A Muszynski; J Carel Goslings; Nicole P Juffermans Journal: Transfusion Date: 2018-11-21 Impact factor: 3.157